Authors:
Witzke, O
Winterhagen, T
Saller, B
Roggenbuck, U
Lehr, I
Philipp, T
Mann, K
Reinhardt, W
Citation: O. Witzke et al., Transient stimulatory effects on pituitary-thyroid axis in patients treated with interleukin-2, THYROID, 11(7), 2001, pp. 665-670
Authors:
Witzke, O
Wheeler, PR
Barbara, JAJ
Gaspar, MC
Morris, PJ
Wood, KJ
Citation: O. Witzke et al., Suppression mediated by anergic CD4(+) T cells requires stimulation by MHC-peptide complexes and can be induced in the presence of costimulation, TRANSPLANT, 72(3), 2001, pp. 369-376
Authors:
Ensminger, SM
Spriewald, BM
Sorensen, HV
Witzke, O
Flashman, EG
Bushell, A
Morris, PJ
Roe, ML
Rahemtulla, A
Wood, KJ
Citation: Sm. Ensminger et al., Critical role for IL-4 in the development of transplant arteriosclerosis in the absence of CD40-CD154 costimulation, J IMMUNOL, 167(1), 2001, pp. 532-541
Authors:
Lutkes, P
Witzke, O
Philipp, T
Schmitt, HJ
Heemann, U
Citation: P. Lutkes et al., Immunization and medical recommendations for patients travelling after transplantation, DEUT MED WO, 125(34-35), 2000, pp. 1011-1016
Authors:
Ensminger, SM
Spriewald, BM
Witzke, O
Morrison, K
Van Maurik, A
Morris, PJ
Rose, ML
Wood, KJ
Citation: Sm. Ensminger et al., Intragraft interleukin-4 mRNA expression after short-term CD154 blockade may trigger delayed development of transplant arteriosclerosis in the absence of CD8+T cells, TRANSPLANT, 70(6), 2000, pp. 955-963
Authors:
Barbara, JAJ
Turvey, SE
Kingsley, CI
Spriewald, BM
Hara, M
Witzke, O
Morris, PJ
Wood, KJ
Citation: Jaj. Barbara et al., Islet allograft rejection can be mediated by CD4(+) alloantigen experienced, direct pathway T cells of Th1 and Th2 cytokine phenotype, TRANSPLANT, 70(11), 2000, pp. 1641-1649
Authors:
Niimi, PS
Witzke, O
Bushell, A
Hara, M
Morris, PJ
Wood, KJ
Citation: Ps. Niimi et al., Nondepleting anti-CD4 monoclonal antibody enhances the ability of oral alloantigen delivery to induce indefinite survival of cardiac allografts: Oraltolerance to alloantigen, TRANSPLANT, 70(10), 2000, pp. 1524-1528
Authors:
Niimi, M
Roelen, DL
Witzke, O
van Rood, JJ
Claas, FHJ
Wood, KJ
Citation: M. Niimi et al., The importance of H-2 haplotype sharing in the induction of specific unresponsiveness by pretransplant blood transfusions, TRANSPLANT, 69(3), 2000, pp. 411-417
Authors:
Ensminger, SM
Witzke, O
Spriewald, BM
Morrison, K
Morris, PJ
Rose, ML
Wood, KJ
Citation: Sm. Ensminger et al., CD8(+) T cells contribute to the development of transplant arteriosclerosis despite CD154 blockade, TRANSPLANT, 69(12), 2000, pp. 2609-2612
Authors:
Jones, ND
Van Maurik, A
Hara, M
Spriewald, BM
Witzke, O
Morris, PJ
Wood, KJ
Citation: Nd. Jones et al., CD40-CD40 ligand-independent activation of CD8(+) T cells can trigger allograft rejection, J IMMUNOL, 165(2), 2000, pp. 1111-1118
Authors:
Heemann, U
Szabo, A
Hamar, P
Muller, V
Witzke, O
Lutz, J
Philipp, T
Citation: U. Heemann et al., Lipopolysaccharide pretreatment protects from renal ischemia/reperfusion injury - Possible connection to an interleukin-6-dependent Pathway, AM J PATH, 156(1), 2000, pp. 287-293
Authors:
Reinhardt, W
Sauter, V
Jockenhovel, F
Kummer, G
Uppenkamp, M
Witzke, O
Philipp, T
Reinwein, D
Mann, K
Citation: W. Reinhardt et al., Unique alterations of thyroid function parameters after i.v. administration of alkylating drugs (cyclophosohamide and ifosfamide), EXP CL E D, 107(3), 1999, pp. 177-182
Authors:
Niimi, M
Hava, M
Witzke, O
Morris, PJ
Wood, KJ
Citation: M. Niimi et al., Donor resting B cells induce indefinite prolongation of fully allogeneic cardiac grafts when delivered with anti-immunoglobulin-D monoclonal antibody: Evidence for tolerogenicity of donor resting B cells in vivo, TRANSPLANT, 66(12), 1998, pp. 1786-1792